Exercise eases fatigue for melanoma patients on immunotherapy

NCT ID NCT06985056

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study looks at whether a 12-week supervised exercise program can reduce fatigue and improve quality of life in adults with stage IIb-IV melanoma who are receiving immunotherapy or targeted therapy. Participants are randomly assigned to either an exercise group (online sessions plus some in-clinic training) or a control group with no structured exercise. The goal is to see if regular physical activity helps with tiredness, thinking skills, and overall well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fatigue melanoma Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Essen

    RECRUITING

    Essen, 45147, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.